{
  "id": 8361964,
  "title": "Corcept Therapeutics president Vieira sells $29,842 of stock",
  "url": "https://urgent.news/2026/09/19/corcept-therapeutics-president-vieira-sells-29-842-of-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-19T02:00:56.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/corcept-therapeutics-president-vieira-sells-29842-of-stock-93CH-4908036"
  },
  "original_language": "en",
  "account": "Corcept Therapeutics' President Roberto Vieira sold 296 shares of the company's stock on September 16, 2026. Each share was sold for $100.82, resulting in a total of $29,842. The stock has increased by 224% over the past six months, driven by improving fundamentals. This transaction was part of a pre-planned 10b5-1 trading plan Vieira adopted in June 2026. After this sale, he still owns 3,946 shares, including shares from unvested restricted stock awards that are set to vest in a year, provided he meets certain requirements. Despite some analysts suggesting the stock is overvalued, the company has a \"GOOD\" financial health score. Recently, Corcept Therapeutics reported strong second-quarter 2026 earnings, with revenue up 32% year-over-year. The company has also raised its revenue outlook for the year. Analysts have raised their price targets for the stock, reflecting continued growth in their core business.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}